JCR Pharmaceuticals (OTCMKTS:JCRRF) Stock Price Down 33.8% – Here’s Why

by · The Cerbat Gem

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report)’s stock price traded down 33.8% during mid-day trading on Monday . The stock traded as low as $3.1450 and last traded at $3.1450. 1,000 shares traded hands during mid-day trading, an increase of 100% from the average session volume of 500 shares. The stock had previously closed at $4.75.

JCR Pharmaceuticals Stock Down 33.8%

The firm has a 50 day moving average price of $4.15 and a 200-day moving average price of $4.33.

About JCR Pharmaceuticals

(Get Free Report)

JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.

In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.

Featured Stories